Kovacs, Gabor T.· Norman, Robert (22 Φεβρουαρίου 2007). Polycystic Ovary Syndrome. Cambridge University Press. σελ. 4. ISBN9781139462037. Ανακτήθηκε στις 29 Μαρτίου 2013.
O'Brien, William T. (1 Ιανουαρίου 2011). Top 3 Differentials in Radiology. Thieme. σελ. 369. ISBN978-1-60406-228-1. Ανακτήθηκε στις 30 Αυγούστου 2014. Ultrasound findings in PCOS include enlarged ovaries with peripheral follicles in a "string of pearls" configuration.
«Androgens in polycystic ovary syndrome: the role of exercise and a diet». Seminars in Reproductive Medicine27 (4): 306–15. 2009. doi:10.1055/s-0029-1225258. PMID19530064.
«The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome». Fertil. Steril.93 (6): 1864–9. 2010. doi:10.1016/j.fertnstert.2008.12.024. PMID19171332.
«Adiposity and metabolic dysfunction in polycystic ovary syndrome». Horm Mol Biol Clin Investig21 (2): 107–16. February 2015. doi:10.1515/hmbci-2015-0008. PMID25781555.
«Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?». Diabetes Metab. Res. Rev.24 (7): 520–32. October 2008. doi:10.1002/dmrr.872. PMID18615851.
Filippou, P; Homburg, R (1 July 2017). «Is foetal hyperexposure to androgens a cause of PCOS?». Human Reproduction Update23 (4): 421–432. doi:10.1093/humupd/dmx013. PMID28531286.
Draper (2003). «Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency». Nature Genetics34 (4): 434–439. doi:10.1038/ng1214. PMID12858176.
«Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome». J. Clin. Endocrinol. Metab.91 (1): 336–40. 2006. doi:10.1210/jc.2005-1696. PMID16249279.
«Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis». Hum. Reprod. Update19 (3): 268–88. 2013. doi:10.1093/humupd/dms059. PMID23303572.
«Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature». J. Clin. Endocrinol. Metab.91 (3): 781–5. 2006. doi:10.1210/jc.2005-2153. PMID16418211.
«Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome». Best Pract Res Clin Obstet Gynaecol18 (5): 671–83. 2004. doi:10.1016/j.bpobgyn.2004.05.001. PMID15380140.
«Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society». Hum. Reprod. Update20 (3): 334–52. 2013. doi:10.1093/humupd/dmt061. PMID24345633.
«The physiology and clinical utility of anti-Mullerian hormone in women». Human Reproduction Update20 (3): 370–85. 2014. doi:10.1093/humupd/dmt062. PMID24430863.
«Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications». Hum. Reprod. Update20 (5): 688–701. 2014. doi:10.1093/humupd/dmu020. PMID24821925.
Garvey, WT; Mechanick, JI; Brett, EM; Garber, AJ; Hurley, DL; Jastreboff, AM; Nadolsky, K; Pessah-Pollack, R και άλλοι. (July 2016). «American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity». Endocrine Practice22 Suppl 3: 1–203. doi:10.4158/EP161365.GL. PMID27219496.
«Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines». Hum. Reprod. Update19 (5): 432. 2013. doi:10.1093/humupd/dmt015. PMID23727939.
«The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review». European Journal of Endocrinology169 (6): 853–65. 2013. doi:10.1530/EJE-13-0617. PMID24044903.
Huang, G; Coviello, A (December 2012). «Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome». Current Opinion in Endocrinology, Diabetes and Obesity19 (6): 512–9. doi:10.1097/med.0b013e32835a000e. PMID23108199.
«The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence». J Obstet Gynaecol29 (6): 467–72. 2009. doi:10.1080/01443610902829414. PMID19697191.
Tanbo, Tom; Mellembakken, Jan; Bjercke, Sverre; Ring, Eva; Åbyholm, Thomas; Fedorcsak, Peter (October 2018). «Ovulation induction in polycystic ovary syndrome». Acta Obstetricia et Gynecologica Scandinavica97 (10): 1162–1167. doi:10.1111/aogs.13395. ISSN1600-0412. PMID29889977.
Hu, Shifu; Yu, Qiong; Wang, Yingying; Wang, Mei; Xia, Wei; Zhu, Changhong (May 2018). «Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials». Archives of Gynecology and Obstetrics297 (5): 1081–1088. doi:10.1007/s00404-018-4688-6. ISSN1432-0711. PMID29392438.
Practice Committee of the American Society for Reproductive Medicine (September 2017). «Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline». Fertility and Sterility108 (3): 426–441. doi:10.1016/j.fertnstert.2017.06.026. ISSN1556-5653. PMID28865539.
«Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity». Fertil. Steril.73 (1): 150–6. 2000. doi:10.1016/S0015-0282(99)00468-9. PMID10632431.
«Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis». Hum. Reprod. Update16 (4): 347–63. 2010. doi:10.1093/humupd/dmq001. PMID20159883.
«Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis». Hum. Reprod.26 (9): 2442–51. 2011. doi:10.1093/humrep/der197. PMID21725075.
Becerra-Fernández, Antonio; Pérez-López, Gilberto; Román, Miriam Menacho; Martín-Lazaro, Juan F.; Lucio Pérez, María Jesús; Asenjo Araque, Nuria; Rodríguez-Molina, José Miguel; Berrocal Sertucha, María Carmen και άλλοι. (1 August 2014). «Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre». Endocrinología y Nutrición61 (7): 351–358. doi:10.1016/j.endonu.2014.01.010. PMID24680383.
«How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?». Clin. Endocrinol.37 (2): 127–34. 1992. doi:10.1111/j.1365-2265.1992.tb02296.x. PMID1395063.
«The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women». Aust N Z J Obstet Gynaecol34 (1): 67–72. 1994. doi:10.1111/j.1479-828X.1994.tb01041.x. PMID8053879.
«Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome». Fertil. Steril.67 (3): 452–8. 1997. doi:10.1016/S0015-0282(97)80068-4. PMID9091329.
Christine Cortet-Rudelli· Didier Dewailly (21 Σεπτεμβρίου 2006). «Diagnosis of Hyperandrogenism in Female Adolescents». Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health.am. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Σεπτεμβρίου 2007. Ανακτήθηκε στις 21 Νοεμβρίου 2006.
«Androgens in polycystic ovary syndrome: the role of exercise and a diet». Seminars in Reproductive Medicine27 (4): 306–15. 2009. doi:10.1055/s-0029-1225258. PMID19530064.
«The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome». Fertil. Steril.93 (6): 1864–9. 2010. doi:10.1016/j.fertnstert.2008.12.024. PMID19171332.
«Adiposity and metabolic dysfunction in polycystic ovary syndrome». Horm Mol Biol Clin Investig21 (2): 107–16. February 2015. doi:10.1515/hmbci-2015-0008. PMID25781555.
«Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?». Diabetes Metab. Res. Rev.24 (7): 520–32. October 2008. doi:10.1002/dmrr.872. PMID18615851.
Filippou, P; Homburg, R (1 July 2017). «Is foetal hyperexposure to androgens a cause of PCOS?». Human Reproduction Update23 (4): 421–432. doi:10.1093/humupd/dmx013. PMID28531286.
Draper (2003). «Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency». Nature Genetics34 (4): 434–439. doi:10.1038/ng1214. PMID12858176.
«The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS)». Endokrynol Pol62 (2): 120–8. 2011. PMID21528473.
«Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome». J. Clin. Endocrinol. Metab.91 (1): 336–40. 2006. doi:10.1210/jc.2005-1696. PMID16249279.
«Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis». Hum. Reprod. Update19 (3): 268–88. 2013. doi:10.1093/humupd/dms059. PMID23303572.
«Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature». J. Clin. Endocrinol. Metab.91 (3): 781–5. 2006. doi:10.1210/jc.2005-2153. PMID16418211.
«Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines». Minerva Ginecol56 (1): 1–6. 2004. PMID14973405.
«Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome». Best Pract Res Clin Obstet Gynaecol18 (5): 671–83. 2004. doi:10.1016/j.bpobgyn.2004.05.001. PMID15380140.
«Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society». Hum. Reprod. Update20 (3): 334–52. 2013. doi:10.1093/humupd/dmt061. PMID24345633.
«Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome». Saudi Med J28 (7): 1039–43. 2007. PMID17603706.
«[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]» (στα Chinese). Zhonghua Yi Xue Za Zhi85 (46): 3266–71. 2005. PMID16409817.
«Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia». Rocz. Akad. Med. Bialymst.48: 131–4. 2003. PMID14737959.
«The physiology and clinical utility of anti-Mullerian hormone in women». Human Reproduction Update20 (3): 370–85. 2014. doi:10.1093/humupd/dmt062. PMID24430863.
«Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications». Hum. Reprod. Update20 (5): 688–701. 2014. doi:10.1093/humupd/dmu020. PMID24821925.
Garvey, WT; Mechanick, JI; Brett, EM; Garber, AJ; Hurley, DL; Jastreboff, AM; Nadolsky, K; Pessah-Pollack, R και άλλοι. (July 2016). «American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity». Endocrine Practice22 Suppl 3: 1–203. doi:10.4158/EP161365.GL. PMID27219496.
«Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines». Hum. Reprod. Update19 (5): 432. 2013. doi:10.1093/humupd/dmt015. PMID23727939.
«The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review». European Journal of Endocrinology169 (6): 853–65. 2013. doi:10.1530/EJE-13-0617. PMID24044903.
Huang, G; Coviello, A (December 2012). «Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome». Current Opinion in Endocrinology, Diabetes and Obesity19 (6): 512–9. doi:10.1097/med.0b013e32835a000e. PMID23108199.
«The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence». J Obstet Gynaecol29 (6): 467–72. 2009. doi:10.1080/01443610902829414. PMID19697191.
Tanbo, Tom; Mellembakken, Jan; Bjercke, Sverre; Ring, Eva; Åbyholm, Thomas; Fedorcsak, Peter (October 2018). «Ovulation induction in polycystic ovary syndrome». Acta Obstetricia et Gynecologica Scandinavica97 (10): 1162–1167. doi:10.1111/aogs.13395. ISSN1600-0412. PMID29889977.
Hu, Shifu; Yu, Qiong; Wang, Yingying; Wang, Mei; Xia, Wei; Zhu, Changhong (May 2018). «Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials». Archives of Gynecology and Obstetrics297 (5): 1081–1088. doi:10.1007/s00404-018-4688-6. ISSN1432-0711. PMID29392438.
Practice Committee of the American Society for Reproductive Medicine (September 2017). «Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline». Fertility and Sterility108 (3): 426–441. doi:10.1016/j.fertnstert.2017.06.026. ISSN1556-5653. PMID28865539.
«Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity». Fertil. Steril.73 (1): 150–6. 2000. doi:10.1016/S0015-0282(99)00468-9. PMID10632431.
«Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis». Hum. Reprod. Update16 (4): 347–63. 2010. doi:10.1093/humupd/dmq001. PMID20159883.
«Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis». Hum. Reprod.26 (9): 2442–51. 2011. doi:10.1093/humrep/der197. PMID21725075.
«Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation». Minerva Ginecol60 (1): 63–75. 2008. PMID18277353.
«Pregnancy complications in women with polycystic ovary syndrome». Semin. Reprod. Med.26 (1): 072–084. 2008. doi:10.1055/s-2007-992927. PMID18181085.
Becerra-Fernández, Antonio; Pérez-López, Gilberto; Román, Miriam Menacho; Martín-Lazaro, Juan F.; Lucio Pérez, María Jesús; Asenjo Araque, Nuria; Rodríguez-Molina, José Miguel; Berrocal Sertucha, María Carmen και άλλοι. (1 August 2014). «Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre». Endocrinología y Nutrición61 (7): 351–358. doi:10.1016/j.endonu.2014.01.010. PMID24680383.
«How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?». Clin. Endocrinol.37 (2): 127–34. 1992. doi:10.1111/j.1365-2265.1992.tb02296.x. PMID1395063.
«The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women». Aust N Z J Obstet Gynaecol34 (1): 67–72. 1994. doi:10.1111/j.1479-828X.1994.tb01041.x. PMID8053879.
«Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome». Fertil. Steril.67 (3): 452–8. 1997. doi:10.1016/S0015-0282(97)80068-4. PMID9091329.
«Intrauterine devices: an update». Am Fam Physician89 (6): 445–50. 2014. PMID24695563.
«What are the symptoms of PCOS?». National Institute of Child Health and Human Development (NICHD). Αρχειοθετήθηκε από το πρωτότυπο(05/23/2013) στις 3 Μαρτίου 2015. Ανακτήθηκε στις 13 Μαρτίου 2015.
«Is there a cure for PCOS?». US Department of Health and Human Services, National Institutes of Health. 23 Μαΐου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Απριλίου 2015. Ανακτήθηκε στις 13 Μαρτίου 2015.
Ada Hamosh (12 Σεπτεμβρίου 2011). «POLYCYSTIC OVARY SYNDROME 1; PCOS1». OMIM. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Ιουλίου 2015. Ανακτήθηκε στις 15 Νοεμβρίου 2011.
«What are the symptoms of PCOS?». National Institute of Child Health and Human Development (NICHD). Αρχειοθετήθηκε από το πρωτότυπο(05/23/2013) στις 3 Μαρτίου 2015. Ανακτήθηκε στις 13 Μαρτίου 2015.
«Is there a cure for PCOS?». US Department of Health and Human Services, National Institutes of Health. 23 Μαΐου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Απριλίου 2015. Ανακτήθηκε στις 13 Μαρτίου 2015.
Christine Cortet-Rudelli· Didier Dewailly (21 Σεπτεμβρίου 2006). «Diagnosis of Hyperandrogenism in Female Adolescents». Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health.am. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Σεπτεμβρίου 2007. Ανακτήθηκε στις 21 Νοεμβρίου 2006.
Ada Hamosh (12 Σεπτεμβρίου 2011). «POLYCYSTIC OVARY SYNDROME 1; PCOS1». OMIM. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Ιουλίου 2015. Ανακτήθηκε στις 15 Νοεμβρίου 2011.
Tanbo, Tom; Mellembakken, Jan; Bjercke, Sverre; Ring, Eva; Åbyholm, Thomas; Fedorcsak, Peter (October 2018). «Ovulation induction in polycystic ovary syndrome». Acta Obstetricia et Gynecologica Scandinavica97 (10): 1162–1167. doi:10.1111/aogs.13395. ISSN1600-0412. PMID29889977.
Hu, Shifu; Yu, Qiong; Wang, Yingying; Wang, Mei; Xia, Wei; Zhu, Changhong (May 2018). «Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials». Archives of Gynecology and Obstetrics297 (5): 1081–1088. doi:10.1007/s00404-018-4688-6. ISSN1432-0711. PMID29392438.
Practice Committee of the American Society for Reproductive Medicine (September 2017). «Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline». Fertility and Sterility108 (3): 426–441. doi:10.1016/j.fertnstert.2017.06.026. ISSN1556-5653. PMID28865539.